Gushen Jiedu capsule (GSJD) is a formula that has been widely used in traditional Chinese medicine for the prevention and treatment of diabetic nephropathy (DN). However, the mechanism underlying the protective effects of GSJD on DN is still unclear. This study was performed to clarify the therapeutic effects of GSJD on DN and its underlying mechanisms. High-fat diet-and streptozotocin-induced DN rats were treated with or without GSJD suspension by gavage for 8 weeks, and biochemical changes in blood and urine were analysed. Kidneys were isolated for histological, TUNEL and Western blot analysis. Compared to the DN group, the GSJD-treated groups exhibited decreased urinary albumin, ameliorated renal dysfunction, including serum creatinine and blood urea nitrogen, and attenuated total cholesterol, triglyceride and total protein levels. However, there were no significant effects of GSJD on body weight, fasting blood glucose or albuminuria. Histology showed that GSJD could retard the progression of DN and decrease the apoptosis rate from 52% to less than 20%. Western blot analysis showed that GSJD could regulate the mitochondrial apoptotic pathway by downregulating the expression of Bax and upregulating the expression of BCL-2 in the kidneys of DN rats. Moreover, the Akt pathway, an upstream signalling pathway of the BCL-2 family, was also ameliorated by GSJD. Further, the podocyte foot process markers podocin and nephrin were upregulated by GSJD in DN rats. This study demonstrated that GSJD might play a renoprotective role by inhibiting apoptosis and regulating the mitochondrial apoptotic and Akt pathways during pathological changes in DN. Diabetic nephropathy (DN) is a diabetes-induced microvascular complication that is responsible for 50% of all cases of end-stage renal disease (ESRD) and is characterized by hyperglycaemia, continuous albuminuria, high blood pressure and impaired renal function 1-3. Additionally, DN is a major risk factor for mortality in patients with diabetic complications worldwide 4,5. Hence, the prevention and treatment of DN have become a serious health issue, and the development of DN medications would be beneficial. Traditional Chinese medicine (TCM) has been used in the treatment of diabetes and related complications for thousands of years in China, which emphasizes the whole regulatory action on the human body 6,7. Thus, TCM formulae have become an important source for the discovery of new medications to prevent and treat DN 8,9. For instance, the NaoXinTong capsule 10 improves glomerular function, inhibits extracellular matrix accumulation, activates the insulin signalling pathway and improves glucose metabolism in db/db mice, suggesting a favourable effect on kidney function. The Gushen Jiedu capsule (GSJD) originated from the classic kidney-tonifying prescription of "Shuilu Erxian Dan" in the Song Dynasty (1170 AD) in China (Supplementary Fig. S1), containing Semen Euryales, Fructus Rosa laevigata, Rhizome Coptis chinensis, Rhizome Rheum tanguticum, Radix Astragalus membranaceus and ...